NEW YORK, Dec. 4, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City announces an investigation against Acorda Therapeutics, Inc. (Nasdaq: ACOR)("Acorda" or the "Company") for possible violations of federal securities laws.
On November 15, 2017, Acorda disclosed that "it has increased the frequency of blood cell count monitoring for participants to weekly in its Phase 3 program of tozadenant for Parkinson's disease...in response to cases of agranulocytosis, possibly drug-related, and in some cases associated with sepsis and death." Acorda further disclosed that "[t]here have been seven cases of sepsis, all in the tozadenant groups, five of which were fatal." Following this news, shares of Acorda fell $11.20 per share or over 39% from its previous closing price to close at $17.00 per share on November 15, 2017.
Mr. Monteverde would like to personally discuss with you how to potentially recover your monetary losses.
Click here for more information: http://monteverdelaw.com/securities/. It is free and there is no cost or obligation to you.
Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm committed that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates PC lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013 and 2017, an award given to less than 2.5% of attorneys in a particular field.
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave, Suite 4405
New York, NY 10118
United States of America
Tel: (212) 971-1341
Attorney Advertising. (C) 2017 Monteverde & Associates PC. Prior results do not guarantee a similar outcome with respect to any future matter.
View original content with multimedia:http://www.prnewswire.com/news-releases/act-now-monteverde--associates-pc-announces-an-investigation-of-acorda-therapeutics-inc--acor-300566238.html
SOURCE Monteverde & Associates PC